WHO Sends 70k Doses of Merck's Ervebo Vaccine to Contain Congo's Ebola Outbreak

The Democratic Republic of Congo has been allocated 70,000 doses of Merck's Ervebo vaccine for Ebola, according to the World Health Organization (WHO). This allocation is in an effort to contain the country's biggest-ever outbreak of the deadly disease.

The WHO made this announcement on Thursday, providing further details about the vaccine distribution. The Ervebo vaccine has been shown to be effective in preventing Ebola, and its use will likely play a crucial role in controlling the spread of the virus.

The DRC has been battling its largest-ever outbreak of Ebola, with over 3,300 reported cases since August 2018. The WHO's allocation of vaccines is seen as a significant step towards containing the outbreak.